Month: February 2016
-
Vaccine Developed to Stop Synthetic Opioids
17 February 2016. Fentanyl is a synthetic opioid drug for treating severe pain after surgery, and in some cases chronic pain, but is also highly addictive and increasingly abused, with growing numbers of overdose deaths. Researchers from Scripps Research Institute in La Jolla, California developed a vaccine that in lab mice prevents ingredients in fentanyl…
-
Biotech Reviewing Stanford Immuno-Stem Cell Technology
16 February 2016. A biotechnology company in Los Angeles is evaluating a technology developed at Stanford University for transferring DNA of immune system cells to a patient’s own stem cells to produce immunotherapies for treating cancer. The agreement with Stanford gives ImmunoCellular Therapeutics Ltd. an option to license the technology from the lab of immunologist…
-
Company Hosts Cancer Genome Cloud, Raises $45 Million
16 February 2016. Seven Bridges Genomics, a computational biology company, unveiled its cloud-based cancer genome data sets, in one of three pilot tests for National Cancer Institute. The Cambridge, Massachusetts enterprise also raised $45 million in its first venture funding round. National Cancer Institute, part of National Institutes of Health, aims to make the Cancer…
-
Virtual Reality Seen Helping People with Depression
15 February 2016. Individuals suffering from depression often express a high degree of self-criticism to the point it interferes with recovery from their disorder. Researchers from University College London showed in a pilot study that a virtual reality exercise could increase feelings of self-compassion and reduce the severity of depression, in some cases with enough…
-
Harnessing Big Data for Precision Medicine
13 February 2016. Precision medicine aims to match individualized genomic data with therapies to provide personalized treatments for people with disease. A panel today (13 February) at the American Association for Advancement of Science or AAAS 2016 annual meeting, described how big data — finding insights in large data sets — help make precision medicine…
-
What it Takes to Innovate in the Old Economy
12 February 2016. Innovation is important throughout the modern economy, particularly in established industries that may lack the excitement of hot new sectors like biotechnology. A panel at the American Association for the Advancement of Science, or AAAS 2016 annual meeting today (12 February) in Washington, D.C. examined ways of creating innovation in these legacy…
-
Starting Tomorrow, Reporting Live from AAAS
11 February 2016. Starting tomorrow, Science & Enterprise will report live from the American Association for Advancement of Science annual meeting in Washington, D.C. Watch for updates during the weekend through Monday. * * *
-
Alliance Creating PTSD Knowledge Base
11 February 2016. A collaboration of three organizations and companies in the U.S. and Germany is building an authoritative and systematic collection of research on post-traumatic stress disorder or PTSD. The PTSD KnowledgeMap, as it’s called, is a project of Cohen Veterans Bioscience, Exaptive Inc,. and Fraunhofer Institute for Algorithms and Scientific Computing, and will…
-
Gene Editing Enlisted to Fight Citrus Greening
11 February 2016. Plant scientists at University of California in Riverside plan to use genome editing to develop varieties of citrus fruit resistant to a bacterial disease devastating crops in the U.S. and other parts of the world. The five-year research project led by UC-Riverside plant pathologist Wenbo Ma is funded by a $4 million…
-
$45M Raised by Protein Folding Drug Discovery Company
10 February 2016. A company discovering new treatments that address errant folding of proteins causing neurological disorders raised $45 million in its first venture funding round. Yumanity Therapeutics, a spin-off enterprise from the Whitehead Institute affiliated with MIT, started in December 2014 and aims to discover therapies for neurodegenerative diseases caused by misfolded proteins. Yumanity…